enGenome will participate in the American College of Medical Genetics and Genomics (ACMG) Annual Meeting, taking place in Baltimore from March 10–14, 2026. The company will welcome attendees at booth #2311.

Focus on Scalable Variant Interpretation

At ACMG 2026, enGenome will highlight eVai, its AI-driven variant interpretation platform designed to support clinical genetics teams in moving efficiently from sequencing data to diagnosis.

As genomic testing volumes continue to increase, clinical laboratories face the challenge of maintaining accuracy and consistency while managing growing case loads. eVai is designed to support scalable interpretation workflows without compromising clinical confidence.

Key Highlights of eVai

• Winner of the NIH-funded CAGI6 Challenge, demonstrating validated diagnostic performance in real-world scenarios

• Automated ACMG guideline application, enabling standards-aligned and consistent variant classification

• Intelligent variant prioritization, helping clinicians focus on the most relevant candidate diagnoses

• Digenic and oligogenic interpretation, supported by a rigorously benchmarked model that predicts pathogenic gene combinations and allows users to explore candidate pairs with supporting literature when available
  

ACMG remains one of the leading global meetings for clinical genetics professionals, bringing together clinicians, researchers, and laboratory leaders from around the world.

Attendees interested in learning more about scalable and AI-supported variant interpretation workflows are invited to visit enGenome at booth #2311 during the meeting.

About enGenome

enGenome offers innovative solutions for interpreting sequencing data. eVai, the flagship product, is a cloud-based solution fueled by artificial intelligence, that excels in prioritizing genetic variants and has been awarded by the NIH-funded CAGI6 challenge as best performing predictor, elevating diagnostic yield by 12.5%.

The latest release is VarChat, an open-access platform integrating Generative AI that searches and delivers informative text from current scientific literature on genetic variants.

Media Contact: Giovana Herold - marketing@engenome.com

For more information on the conference, access the official website